Testing Different Theories of Smoking Cessation: An Intervention Study

Overview

The topic of this research is cigarette smoking cessation. We designed four smoking cessation booklets. These booklets are designed for smokers who differ in their motivation to quit smoking. We will compare different ways of matching booklets to smokers who vary in their motivation to quit smoking.

Full Title of Study: “Testing Alternative Stage Models of Smoking Cessation: An Intervention Study”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: Single (Participant)
  • Study Primary Completion Date: November 2012

Detailed Description

The topic of the proposed research is adult cigarette smoking cessation. The PI has designed a set of four smoking cessation booklets. These booklets cover different aspects of the smoking cessation process, and are designed to help smokers who differ in their levels of motivation to quit smoking. The purpose of the study is to compare different ways of matching booklets to smokers who vary in their motivation to quit smoking. Adult smokers (N=1,826) will be recruited via newspaper ads, fliers, and possibly other methods, depending on response rates. Participants will enroll in the study by telephoning the research staff in response to the advertisements. The smoking cessation booklets and surveys will be sent via US Mail. Smokers will be assigned randomly to one of three intervention conditions. Participants at baseline will answer a series of survey items regarding their motivation and plans (or lack thereof) for quitting smoking. The three intervention conditions differ in that each employs a different method of matching smokers to one of the four booklets. Essentially, we are comparing different strategies for allocating booklets to smokers. Participants will be surveyed two weeks and two months after receiving their smoking cessation booklet.

Interventions

  • Behavioral: Smoking cessation booklet

Arms, Groups and Cohorts

  • Active Comparator: Stage of Change
  • Experimental: Common Sense Model
  • Active Comparator: Action Model

Clinical Trial Outcome Measures

Primary Measures

  • Smoking Status
    • Time Frame: two months
    • Participants will be asked if they are still smoking cigarettes, or if they have ceased to smoke cigarettes.

Secondary Measures

  • Motivation to quit smoking
    • Time Frame: two months
    • Participants will be asked about the extent to which they are motivated to quit smoking (for example, if they intend to quit smoking or do not intend to quit smoking).

Participating in This Clinical Trial

Inclusion Criteria

  • must be a current smoker who smokes at least three cigarettes per day – must have smoked at least 100 cigarettes in their lifetime. – must be able to read English so that they can read the intervention booklets and complete questionnaires in English. – must have a mailing address so that they can receive booklets and questionnaires in the mail. – must be age 18 or older. – must live in Hawaii Exclusion Criteria:

  • not a current smoker – smokes fewer than three cigarettes per day – has not smoked at least 100 cigarettes in their lifetime – cannot read English – has no mailing address – is under 18

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • University of Hawaii
  • Provider of Information About this Clinical Study
    • Principal Investigator: Thaddeus Herzog, Principal Investigator – University of Hawaii
  • Overall Official(s)
    • Thaddeus A Herzog, Ph. D., Principal Investigator, University of Hawaii Cancer Research Center

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.